NCR3 and neoplasm: In addition to the Ab portion recognizing the tumor antigen of interest, in the presented cases CD20, and the Ab targeting the NK cells via the NKp46 receptor that differently from Nkp30, NKG2D or CD16 is retained in tumor infiltrating NK.